Summary of Study ST002363

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001518. The data can be accessed directly via it's Project DOI: 10.21228/M8GH72 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Study ID	ST002363
Study Title	[U-13C]glucose tracing in NT, AOA or EGCG treated activated CD8+ T cells
Study Summary	CD8+ T cells were activated with plate-bound anti-CD3 and soluble anti-CD28 for 24 hours without (NT), or with AOA (250uM) or EGCG (500uM) treatment. CD8+ T cells were pulsed with [U-13C]glucose. Intracellular glucose-derived glutamate levels were quantified using MS.
Institute	Johns Hopkins University
Last Name	Xu
First Name	Wei
Address	1650 Orleans Street, Baltimore, MD 21287, USA.
Email	wxu29@jhmi.edu
Phone	443-220-9936
Submit Date	2022-11-28
Raw Data Available	Yes
Raw Data File Type(s)	d
Analysis Type Detail	LC-MS
Release Date	2022-12-15
Release Version	1

Select appropriate tab below to view additional metadata details:

Treatment:

Treatment ID:	TR002464
Treatment Summary:	CD8+ T cells were isolated from spleens and lymph nodes from C57BL/6J mice. Cells were activated with plate-bound anti-CD3 and soluble anti-CD28 for 24 hours, without (NT) or with AOA (250uM) or EGCG (500uM) treatment. CD8+ T cells were counted and resuspended in full media containing 11 mM [U-13C]glucose at 2 E6 mL-1. Normal FBS was substituted with dialyzed FBS. Cells were collected for LC-MS analysis 4-6 hrs post incubation.

Treatment ID:

TR002464

Treatment Summary:

CD8+ T cells were isolated from spleens and lymph nodes from C57BL/6J mice. Cells were activated with plate-bound anti-CD3 and soluble anti-CD28 for 24 hours, without (NT) or with AOA (250uM) or EGCG (500uM) treatment. CD8+ T cells were counted and resuspended in full media containing 11 mM [U-13C]glucose at 2 E6 mL-1. Normal FBS was substituted with dialyzed FBS. Cells were collected for LC-MS analysis 4-6 hrs post incubation.